The molecular mechanisms underlying remission of depression remain unclear, although neurotrophic growth factors—like brain-derived neurotrophic factor—may have an important role during remission processes.44 One reason for the lack in association between clinical response and in vitro cell proliferation effects of in vitro fluoxetine treatment may be that the cell model in blood-derived LCLs is not suitable for studying brain-specific antidepressant-induced proliferative effects owing to lack of relevant neuronal pathways. The gene discussed is BDNF; the disease is depressive symptom measurement.